Bioben sliced and diced its statistics and now they claim that their amyloid-theory Alzheimer's drug that failed in Phase II actually does work after all -- when you look at one specific dose and use different statistical methods.

Uh huh..

https://endpts.com/that-alzheimers-drug-that-...a%20winner